Cargando…
EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogramming
The molecular mechanisms driving metastatic progression in triple-negative breast cancer (TNBC) patients are poorly understood. In this study, we demonstrate that epidermal growth factor-like 9 (EGFL9) is significantly upregulated in basal-like breast cancer cells and associated with metastatic prog...
Autores principales: | Meng, Fanyan, Wu, Ling, Dong, Lun, Mitchell, Allison V., James Block, C., Liu, Jenney, Zhang, Haijun, Lu, Qing, Song, Won-min, Zhang, Bin, Chen, Wei, Hu, Jiani, Wang, Jian, Yang, Qifeng, Hüttemann, Maik, Wu, Guojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834558/ https://www.ncbi.nlm.nih.gov/pubmed/31695034 http://dx.doi.org/10.1038/s41467-019-13034-3 |
Ejemplares similares
-
Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma
por: Lohberger, Birgit, et al.
Publicado: (2021) -
Targeting the HGF-cMET Axis in Hepatocellular Carcinoma
por: Venepalli, Neeta K., et al.
Publicado: (2013) -
Role of cMET in the Development and Progression of Colorectal Cancer
por: Pérez-Vargas, Juan Carlos Samamé, et al.
Publicado: (2013) -
DDR2 Coordinates EMT and Metabolic Reprogramming as a Shared Effector of FOXQ1 and SNAI1
por: Mitchell, Allison V., et al.
Publicado: (2022) -
The Role of cMET in Gastric Cancer—A Review of the Literature
por: Van Herpe, Filip, et al.
Publicado: (2023)